---
schema_version: "secwatch.filing_event.v1"
accession: "0001851734-22-000101"
form_type: "8-K"
ticker: "TRAK"
cik: "0000050471"
company_name: "ReposiTrak, Inc."
filed_at: "2022-02-15T23:59:59+00:00"
generated_at: "2026-06-27T08:09:06.756193+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Park City Group Q2: Operating income up 148% to $958K; 99% recurring SaaS revenue

## Summary
- Total revenue $4.4M (-16% YoY) due to planned phase-out of non-recurring revenue; recurring SaaS revenue up 7% to $4.3M.
- Operating income $958K (+148% YoY); GAAP net income $872K (prior year had $1.1M PPP gain; ex that, net income +66%).
- EPS $0.04 vs $0.08; cash from operations $3.1M YTD; cash $21.7M at Dec 31, 2021.
- Repurchased 244,552 shares at avg $5.85 in Q2 for $1.43M; $10.5M remaining on buyback authorization.
- CEO cites FDA traceability mandates as large opportunity; company pivoting to SaaS model with 99% recurring revenue.

## SEC filing metadata
- accession: 0001851734-22-000101
- form_type: 8-K
- ticker: TRAK
- cik: 0000050471
- company_name: ReposiTrak, Inc.
- filed_at: 2022-02-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/50471/000185173422000101/0001851734-22-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/50471/000185173422000101/pcyg20220215_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001851734-22-000101
- JSON: https://secwatch.observer/filing/0001851734-22-000101.json
- Plain text: https://secwatch.observer/filing/0001851734-22-000101.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.